RecruitingNot ApplicableNCT06702813

Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in ICU Patients


Sponsor

Shanghai Zhongshan Hospital

Enrollment

45 participants

Start Date

Nov 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Atelectasis, hypoxemia, and ineffective sputum clearance are common problems in ICU patients. Continuous High-Frequency Oscillation (CHFO) is often considered to have a protective effect on the lungs. CHFO provides effective gas exchange at supraphysiological frequencies while minimizing pressure fluctuations, producing tidal volumes smaller than dead space, and adjusting around a continuously expanding pressure to optimize end-expiratory lung volume (EELV), thereby improving lung function by achieving and maintaining lung recruitment. However, the physiological effects and safety of CHFO in awake critically ill patients are still lacking relevant research. The objective of this study is to evaluate the comfort, safety, and efficacy of CHFO in awake critically ill patients.


Eligibility

Min Age: 18 MonthsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called High-Frequency Oscillatory Ventilation for people with atelectasis, postoperative, critical illness, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Months to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHigh-Frequency Oscillatory Ventilation

Administer 10 minutes of high-frequency oscillatory ventilation in awake ICU patients.


Locations(1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06702813


Related Trials